These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 10947800

  • 1. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
    Bernardo A, Levi G, Minghetti L.
    Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S, Rattan R, Singh AK, Singh I.
    J Immunol; 2004 Oct 15; 173(8):5196-208. PubMed ID: 15470065
    [Abstract] [Full Text] [Related]

  • 4. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2.
    Petrova TV, Akama KT, Van Eldik LJ.
    Proc Natl Acad Sci U S A; 1999 Apr 13; 96(8):4668-73. PubMed ID: 10200320
    [Abstract] [Full Text] [Related]

  • 5. The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells.
    Drew PD, Chavis JA.
    J Neuroimmunol; 2001 Apr 02; 115(1-2):28-35. PubMed ID: 11282151
    [Abstract] [Full Text] [Related]

  • 6. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2).
    Kielian T, McMahon M, Bearden ED, Baldwin AC, Drew PD, Esen N.
    J Neurochem; 2004 Sep 02; 90(5):1163-72. PubMed ID: 15312171
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
    Chen CW, Chang YH, Tsi CJ, Lin WW.
    J Immunol; 2003 Jul 15; 171(2):979-88. PubMed ID: 12847270
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.
    Rheumatology (Oxford); 2005 Aug 15; 44(8):983-8. PubMed ID: 15840591
    [Abstract] [Full Text] [Related]

  • 9. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis.
    Ajmone-Cat MA, Nicolini A, Minghetti L.
    J Neurochem; 2003 Dec 15; 87(5):1193-203. PubMed ID: 14622099
    [Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H, Di Battista JA, Pelletier JP, Mineau F, Ranger P, Martel-Pelletier J.
    Arthritis Rheum; 2001 Mar 15; 44(3):595-607. PubMed ID: 11263774
    [Abstract] [Full Text] [Related]

  • 11. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B, Hake PW, Mangeshkar P, O'Connor M, Burroughs TJ, Piraino G, Denenberg A, Wong HR.
    Shock; 2007 Nov 15; 28(5):554-63. PubMed ID: 17589386
    [Abstract] [Full Text] [Related]

  • 12. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
    Br J Pharmacol; 2003 Sep 15; 140(2):366-76. PubMed ID: 12970094
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ, Park KS, Chung SY, Sheen YY, Moon DC, Song YS, Kim KS, Song S, Yun YP, Lee MK, Oh KW, Yoon DY, Hong JT.
    J Pharmacol Exp Ther; 2003 Nov 15; 307(2):505-17. PubMed ID: 12966153
    [Abstract] [Full Text] [Related]

  • 14. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
    Janabi N.
    J Immunol; 2002 May 01; 168(9):4747-55. PubMed ID: 11971025
    [Abstract] [Full Text] [Related]

  • 15. Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages.
    Piraino G, Cook JA, O'Connor M, Hake PW, Burroughs TJ, Teti D, Zingarelli B.
    Shock; 2006 Aug 01; 26(2):146-53. PubMed ID: 16878022
    [Abstract] [Full Text] [Related]

  • 16. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun 01; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 17. PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
    Simonin MA, Bordji K, Boyault S, Bianchi A, Gouze E, Bécuwe P, Dauça M, Netter P, Terlain B.
    Am J Physiol Cell Physiol; 2002 Jan 01; 282(1):C125-33. PubMed ID: 11742805
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
    Guyton K, Bond R, Reilly C, Gilkeson G, Halushka P, Cook J.
    J Leukoc Biol; 2001 Apr 01; 69(4):631-8. PubMed ID: 11310850
    [Abstract] [Full Text] [Related]

  • 19. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S, Simonin MA, Bianchi A, Compe E, Liagre B, Mainard D, Bécuwe P, Dauça M, Netter P, Terlain B, Bordji K.
    FEBS Lett; 2001 Jul 13; 501(1):24-30. PubMed ID: 11457450
    [Abstract] [Full Text] [Related]

  • 20. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
    Phulwani NK, Feinstein DL, Gavrilyuk V, Akar C, Kielian T.
    J Neurochem; 2006 Dec 13; 99(5):1389-1402. PubMed ID: 17074064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.